Area of research
Endocrinology, Diabetes and Metabolism · Epidemiology
Research interest
of our academic staff. PhD funding Current funded studentship opportunities. Becky Mayer Centre for Phage Research Find out more about Phage Research and its potential to impact global challenges Phage research Return to the start of Study with us Explore our research
Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement using a modified Delphi approach.
Blood pressure and adverse cardiovascular outcomes in older people with type 2 diabetes and chronic kidney disease: Findings based on the Clinical Practice Research Datalink databases in England.
Burden of long-term conditions and management of people with overweight and obesity: Data from the United Kingdom primary care cohort of the IMPACT-O study.
Trajectories of type 2 diabetes and cancer in 330 000 individuals with prediabetes: 20-year observational study in England.
Prognostic models for all-cause and cardiovascular mortality in type 2 diabetes: Systematic review.
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025.
Age at type 2 diabetes diagnosis and risk of cancer: Cohort study in over 1 million individuals from the TriNetX US Collaborative Network.
The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping Review.
Clustering in multiple long-term conditions: methodological and translational challenges and solutions.
Structured group education programme and accompanying mHealth intervention to promote physical activity in women with a history of gestational diabetes (Baby Steps): 4-year follow-up of a randomised controlled trial.
Global Insights on the Involvement of Ethnic Minority Populations in Health and Social Care Research Priority Setting: A Systematic Scoping Review.
Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study
Secondary causes of diabetes: a crossroad of endocrinology and oncology.
Progression of multiple long-term conditions (multimorbidity) in England: a population-based descriptive study of 49·6 million adults.
Burden and determinants of diabetes in sub-Saharan Africa.
Interventions to prevent and treat multiple long-term conditions and their consequences across the life course: concepts and definitions.
The Utility of Measures of Physical Behavior, Function, and Fitness as Predictors of Mortality.
Corrigendum to "The Healthcare Professionals Attitudes Towards Deprescribing (HATD) tool in older persons with multiple long-term chronic conditions and those on palliative care: A mixed methods study" [Prim. Care Diabetes 19/6 (2025) 646-650].
Correction: Who presents the greatest challenge in intellectual disability research- participants or health and research professionals?
The prevalence of cardiometabolic and renal long-term conditions in individuals with type 2 diabetes mellitus: a global umbrella review.
Global inequality in target attainment among people with diabetes.
Insights from pharmacists in the United Kingdom on the management of medication adherence in hypertension: a cross-sectional survey.
The diagnostic accuracy of blood biomarkers for sarcopenia, sarcopenic obesity, and osteosarcopenia: a meta-analysis.
Diabetes-related complications and multiple long-term conditions in sub-Saharan Africa: determinants and management strategies.
Strengthening diabetes care in sub-Saharan Africa: health systems, digital innovations, lifestyle interventions, and socioeconomic dimensions.
Ethnic differences in healthcare utilisation and diagnosis after first presentation with breathlessness: a retrospective cohort study using UK primary care records.
Association between type 2 diabetes and site-specific fracture risk: A systematic review and meta-analysis of cohort studies including over 13 million participants.
A Systematic Review and Meta-Analysis of Efficacy and Safety of Liraglutide in Patients with Type 2 Diabetes Mellitus.
Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease.
Glycaemic control remains central in type 2 diabetes mellitus management: key learnings from the latest International Diabetes Federation guidelines.